During the past decade, Covance Clinical Research Unit (CRU) Ltd conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance Clinical Research Unit (CRU) Ltd" #1 sponsor was "Pronova BioPharma" with 5 trials, followed by "Biota Scientific Management Pty Ltd" with 3 trials sponsored, "Astellas Pharma Europe B.V." with 2 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored and "NorthSea Therapeutics B.V." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit (CRU) Ltd" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit (CRU) Ltd" are "Healthy" (9 trials), "Healthy Subjects" (3 trials), "Healthy Volunteers" (3 trials), "Influenza" (3 trials) and "Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Covance Clinical Research Unit (CRU) Ltd" in a lesser frequency.

Most popular intervention types in "Covance Clinical Research Unit (CRU) Ltd" are "Drug" (28 trials), "Other" (3 trials), "Dietary Supplement" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "CS-8958 formulated as dry powder" (2 trials), "Pronovum PRF-037" (2 trials), "14C-labeled ASP1707" (1 trials) and "AJM347" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covance Clinical Research Unit (CRU) Ltd" are 20 trials for "All" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Covance Clinical Research Unit (CRU) Ltd". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Covance Clinical Research Unit (CRU) Ltd, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Covance Clinical Research Unit (CRU) Ltd, 30 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".